European Gender Summit
Date
Address
Links
Event Type
Organiser type
Section
Event Location
Event Description
- Through your knowledge as a scientist, decision maker, educator, policy maker, or practitioner, help IDENTIFY the best and most realistic solutions for integrating the gender dimension in research and innovation
- EXCHANGE ideas and views with top-level leaders in science and in public policy on the opportunities for advancing the gender dimension in HORIZON 2020 and in other policy initiatives
- LEARN from leading science institutions about the practical measures that they have already developed to advance gender equality in research and in higher education
- LEARN from the researchers themselves about new discoveries and a better understanding of the role of the gender dimension in many different areas of study, and how these findings can lead to new ideas and new markets for science knowledge
- Through discussion with other participants and consultation with the Summit’s on-line community, help ENRICH the advocacy strategy for excellence science by ensuring that it is sensitive to gender equality issues and to the needs and concerns of society.
Related Events
Securing Europe‘s Raw Material Supply in the Context of Resource Efficiency and EU Industry Policy
There is no energy- and resource efficiency, no climate protection, no future technologies for our modern
world without the use of non-ferrous metals.
Monday 5 November 2012 (day 1)
15:00-16:30: European Parliament Briefing (optional): Enterprise Forum members will have the opportunity to attend a briefing on how the European Parliament works. Paul-Henri Spaak Building, Rue Wiertz, B-1047 Brussels
SMEs are the backbone of the European economy. Of the approximately 20 million SMEs in Europe, one third is active in the field of commerce.
COST will be a partner of the fourth European Innovation Summit to be held at the European Parliament in Brussels under the motto 'Building bridges – Creating Synergies'.
Knowledge4Innovation will be organising the 4th European Innovation Summit from 9 to 10 October 2012 in the European Parliament in Brussels.
An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.
Pages
Events of the week
Jobs
EURACTIV News
- Franco-German nuclear fight foils EU competitiveness agreement
- French farmers no longer want to be ‘top of the class’ in the fight against pesticides
- MEPs spring a surprise by rejecting smoke-free environments resolution
- The Brief – Why the medical community is leaving X
- Poland’s Contribution to Energy Transition for European Competitiveness [Promoted content]